全文获取类型
收费全文 | 462篇 |
免费 | 21篇 |
出版年
2022年 | 5篇 |
2021年 | 20篇 |
2020年 | 5篇 |
2019年 | 7篇 |
2018年 | 9篇 |
2016年 | 11篇 |
2015年 | 8篇 |
2014年 | 16篇 |
2013年 | 26篇 |
2012年 | 24篇 |
2011年 | 38篇 |
2010年 | 19篇 |
2009年 | 16篇 |
2008年 | 13篇 |
2007年 | 16篇 |
2006年 | 21篇 |
2005年 | 6篇 |
2004年 | 15篇 |
2003年 | 12篇 |
2002年 | 12篇 |
2001年 | 8篇 |
2000年 | 8篇 |
1999年 | 3篇 |
1996年 | 7篇 |
1995年 | 4篇 |
1994年 | 5篇 |
1993年 | 5篇 |
1992年 | 11篇 |
1991年 | 10篇 |
1990年 | 8篇 |
1989年 | 9篇 |
1987年 | 6篇 |
1986年 | 4篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 7篇 |
1981年 | 10篇 |
1980年 | 8篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 5篇 |
1974年 | 2篇 |
1973年 | 6篇 |
1972年 | 7篇 |
1970年 | 5篇 |
1969年 | 2篇 |
1964年 | 2篇 |
1963年 | 2篇 |
1962年 | 3篇 |
排序方式: 共有483条查询结果,搜索用时 906 毫秒
411.
412.
D Chakrabarty A Gomes S C Lahiri A K Nag Chaudhuri 《Indian journal of experimental biology》1991,29(5):456-459
Lethal and haemorrhagic activity of Russell's Viper venom was compared against polyvalent bivalent commercial antiserum and monovalent antiserum raised in rabbit. Formaldehyde-detoxified venom offered 7-fold protection against lethal activity and 12.5-fold against haemorrhagic activity of the venom. Whole venom and formaldehyde-detoxified venom along with Freund's complete adjuvant, injected in rabbits produced high titre antiserum. Amongst all the six antiserum tested, the monovalent antiserum raised in rabbit, showed maximum precipitating bands in immunogeldiffusion and immunoelectrophoresis. The toxoid-antiserum offered maximum protection against the venom-induced lethality and the monovalent antiserum offered maximum protection against haemorrhagic activity. 相似文献
413.
414.
415.
Barnett S.; Mulligan E.; Wagerle L. C.; Lahiri S. 《Journal of applied physiology》1988,65(6):2484-2489
To resolve the controversy regarding carotid body blood flow, we used the radioactive microsphere technique for determination of tissue blood flow. We also measured the blood flow to several other tissues in the cat. Blood flow experiments were performed on 13 cats that were anesthetized, paralyzed, and mechanically ventilated with air. Different numbers of differently labeled 9-, 15-, and 25-micron microspheres were injected via a catheter into the left atrium. It was determined that one injection of 5 x 10(6) 15-micron microspheres was appropriate for the determination of carotid body blood flow. Flows to the carotid bodies and other organs by use of this protocol were as follows (ml.min-1.100 g-1, means +/- SE): carotid bodies, 1,417 +/- 143; adrenal glands, 406 +/- 89; left kidney, 355 +/- 69; right kidney, 375 +/- 74; heart, 201 +/- 39; liver 81 +/- 14; pancreas, 80 +/- 21; superior cervical ganglia, 62 +/- 9; carotid artery wall, 2.4 +/- 1.1. The blood flow to the carotid bodies was the highest for any organ. This measurement provides new evidence that tissue blood flow to the carotid body is very high. This high flow is consistent with the prompt physiological reflex functions of the carotid body. 相似文献
416.
417.
418.
419.
420.
Ranjit K. Mehta Sushmita Shukla Susmita G. Ramanand Vishal Somnay Alexander J. Bridges Theodore S. Lawrence Mukesh K. Nyati 《Translational oncology》2021,14(8)
Disruptin is a cell-permeable decoy peptide designed to destabilize activated EGFR, both by inhibiting Hsp90 chaperoning and dissociating the active asymmetric EGFR dimer, which leads to an increase in engagement of activated EGFR with the proteolytic degradation machinery and subsequent loss from the cells. Disruptin is an N-terminally biotinylated nonadecapeptide, with 8 amino acids from the αC-helix-β4 sheet loop of EGFR (S767-C774) fused to a TAT undecapeptide. The S767-R775 loop is at the interface with juxtamembrane domains in the active EGFR dimers and is a binding site for Hsp90. Cellular studies in EGFR-activated tumor cells demonstrated that Disruptin causes the disappearance of EGFR protein from cells over a few hours, a growth inhibitory effect, similar but more effective than the EGFR kinase inhibition. Interestingly, cells without activated EGFR remained unaffected. In vivo studies showed that Disruptin slowed the growth of small tumors. Larger tumors responded to intratumoral injections but did not respond to systemic administration at tolerated doses. Investigation of these results revealed that systemic administration of Disruptin has acute toxicities, mainly related to its TAT peptide moiety. Therefore, we conclude that although the efficacy of both in vitro and in vivo intratumoral injection of Disruptin supports the therapeutic strategy of blocking activated EGFR dimerization, Disruptin is not suitable for further development. These studies also highlight the importance of the chosen models and drug-delivery methods for such investigations. 相似文献